
The ProMOTE Study
@promotestudy
Stage 2. RCT of conventional RARP vs molecularly-targeted intraoperative fluorescence. Trials unit @SITU_Oxford. Funder @CR_UK. CI @lambalastair. @NDSurgicalSci
ID: 1536710065943678977
14-06-2022 14:00:49
59 Tweet
45 Followers
42 Following

Excellent overview of trial portfolios in Urological Malignancies from Aaron Leiblich & Clare Verrill from #Oxford_Urology, & Brent O'Carrigan & Simon Pacey from #CambridgeUrologyGroup SITU Oxford TRANSLATE Trial The ProMOTE Study PART_Trial #WIRE_Trial #ARTIST_Trial


Bryant_Lab gives an excellent overview of the #VANCE_Trial using ChAdOx adenovirus to stimulate 5T4 Cd8+ T cell immune response in #ProstateCancer Encouraging phase 1/2 data Perhaps #PCa not as 'immune dead' as we previously thought... jitc.bmj.com/content/8/1/e0… #OxCamUrol


🚨Focal #radonc boost for #ProstateCancer - can we hit the target? 🎯 Asona Lui, MD, PhD, amazing resident UC San Diego Rad Med, led an international prospective study. Results out today in IJROBP - The Red Journal ASTRO redjournal.org/article/S0360-… UC San Diego Health Moores Cancer Center RSNA ACRO - American College of Radiation Oncology PCF Science 🧵1/n


This is a MUST READ from BJU International for everyone presenting clinical #AI papers. Standardised reporting is essential!!! Follow Responsible Ai UK BJUI Editorial Team's view on artificial intelligence and machine learning - Thalmann - 2023 bjui-journals.onlinelibrary.wiley.com/doi/full/10.11…

Excellent to have our #Oxford_Urology annual #RARP audit from Abhishek Sharma •n=175 •74% attended Maggie's Oxford •0% GG1 (for 5th Yr) •54% pT3 •10% LNDs (n=20 yield) •PSM 19% (13%T2: 25.3%T3) [dropped yrly since radiol Ruth MacPherson joined planning meets] •85% Day 1 d/c
![Alastair Lamb (@lambalastair) on Twitter photo Excellent to have our #Oxford_Urology annual #RARP audit from <a href="/treatyOfSharma/">Abhishek Sharma</a>
•n=175
•74% attended <a href="/maggiesoxford/">Maggie's Oxford</a>
•0% GG1 (for 5th Yr)
•54% pT3
•10% LNDs (n=20 yield)
•PSM 19% (13%T2: 25.3%T3)
[dropped yrly since radiol <a href="/RuthMacPherson/">Ruth MacPherson</a> joined planning meets]
•85% Day 1 d/c Excellent to have our #Oxford_Urology annual #RARP audit from <a href="/treatyOfSharma/">Abhishek Sharma</a>
•n=175
•74% attended <a href="/maggiesoxford/">Maggie's Oxford</a>
•0% GG1 (for 5th Yr)
•54% pT3
•10% LNDs (n=20 yield)
•PSM 19% (13%T2: 25.3%T3)
[dropped yrly since radiol <a href="/RuthMacPherson/">Ruth MacPherson</a> joined planning meets]
•85% Day 1 d/c](https://pbs.twimg.com/media/F6p5mq5WgAA9Edj.jpg)

A great day of golf ⛳️ Huntercombe Golf Club #CaptainsDay in support of UCARE 💙 #DoYouCUs w particular emphasis on fundraising for Nuffield Department of Surgical Sciences research nurse. Much needed to keep running novel trials/lab research to help our patients And my awesome sister won Ladies Longest Drive!!🏆🍾


Inviting appls to #Oxford_Urology pelvic uro-onc fellowship for Aug '24. Approx cases pa 180 RARPs/40 RARCs/600 Bx (TRUS&LATP) Intuitive UK HQ in Oxford Key role in 4 RCTs: -The ProMOTE Study -PART_Trial -IP2 - ATLANTA Trial -FINESSE Close: 15/12 Intv: 22/12 nhsjobs.com/job/UK/Oxfords…


Please come see our poster showing how we use #SpatialTranscriptomics to deduce clonal metastatic relationships in high-risk surgically treated #prostatecancer #LethalClone #Space_Study QUANTUM Biobank Warm House Research & Sandy Figiel will answer all your qus! Oxford Cancer #OxSymp24


Freddie Hamdy drops the 🎤 International Prostate Forum on thought expmt #FocalTherapy as "4th arm" in #ProtecT_Trial Opponent: "well never be able to do RCT of Focal vs RP" FCH: "Here's PART_Trial, our RCT of partial vs radical Tx, international support & recruiting nicely" !! #AUA24


How to convert #RARP & #ProstateBx specimens into #CuttingEdge translational science? State-of-the-Art Tips&Tricks video on #SpatialTranscriptomics analysis w #VisiumV2 Oxford Prostate Cancer Biology Group Nuffield Department of Surgical Sciences Presented by Thines Krishna @ #AUA24 #OrganscaleNodes youtu.be/_jqTHaKSfxo?si…

Today we publish first installment of #PROMOTE_Trial in European Association of Nuclear Medicine (EANM) #EJNMMI journal n=23; 48% pT3b; 43% pN1 Node +ve fluoro n=8 Margin +ve fluoro n=10 Optimal dose of IR800-IAB2M PSMA minibody: 5mg iv 10d pre-RARP The ProMOTE Study funded by Science and Innovation at Cancer Research UK link.springer.com/article/10.100…


TRANSLATE Trial results European Association of Urology (EAU) EAU Madrid, 10am Sunday 23/3/25, Green Area eURO Auditorium 1. #LATP v #TRUS prostate biopsy, n=1126; 1ry outcome GGG>=2 cancer detection, 2ry = infection, other complications, cost-effectiveness; Alastair Lamb Bryant_Lab Nuffield Department of Surgical Sciences OCTRU Trials Hub


Excited to announce #TRANSLATE_Trial outcomes will read out at 10am Sun 23rd March in eURO Auditorium 1 #EAU25, Madrid Synchronous embargoed publication in The Lancet Oncology #LATPvsTRUS - we'll finally give you the answer Hope to see you there! @GUCast Bryant_Lab Alastair Lamb


Breaking news pod - TRANSLATE trial just presented at #EAU25 with co-publication The Lancet Oncology Bryant_Lab Alastair Lamb TRANSLATE Trial. Discussant Declan Murphy Deep dive on GU Cast just released youtu.be/QdWlFy2zrHU?si…

Trial CI Bryant_Lab delighted to read out #TRANSLATE_Trial results during #GameChanger session European Association of Urology (EAU) #EAU25 Thank you to all our investigators, recruiting sites, funders National Institute for Health and Care Research and, most importantly, our 1126 pts! thelancet.com/journals/lanon… Trial visual abstract below ⬇️


V grateful to Declan Murphy for his excellent, provocative & thoughtful "discussant" response to #TRANSLATE_Trial read-out by Bryant_Lab Alastair Lamb Nuffield Department of Surgical Sciences Sashi Kommu Ben Eddy 🇺🇦 Hide Yamamoto Matthew Liew Watch it again in full here ⬇️ youtu.be/O4-wKmhza6Y

Co-Chief Investigator Bryant_Lab outlines #TRANSLATE_TRIAL journey during Nuffield Department of Surgical Sciences #SurgicalGrandRounds this morning. OCTRU Trials Hub SITU Oxford #SGR #Oxford_Urology
